---
document_datetime: 2023-09-21 20:05:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zurampic-epar-all-authorised-presentations_en.pdf
document_name: zurampic-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0225957
conversion_datetime: 2025-12-28 01:54:21.560977
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                     | Pack size                   |
|------------------|-----------------|------------|-----------------------|---------------------------|-----------------------------------------|-----------------------------|
| EU/1/15/1080/001 | Zurampic        | 200 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Aluminium)            | 10 tablets                  |
| EU/1/15/1080/002 | Zurampic        | 200 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Aluminium)            | 28 tablets                  |
| EU/1/15/1080/003 | Zurampic        | 200 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Aluminium)            | 30 tablets                  |
| EU/1/15/1080/004 | Zurampic        | 200 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Aluminium)            | 98 tablets                  |
| EU/1/15/1080/005 | Zurampic        | 200 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Aluminium) authorised | 100 x 1 tablets (unit dose) |

<!-- image -->